# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-14-000043
Filing Date
2014-04-21
Accepted
2014-04-21 17:08:41
Documents
6
Period of Report
2013-12-31
Effectiveness Date
2014-04-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ligand-2014proxystatement.htm | DEF 14A | 855565
2 |  | ligand2014proxystatem_image1.jpg | GRAPHIC | 9775
3 |  | proxymeetingnotice1.jpg | GRAPHIC | 205515
4 |  | proxymeetingnotice2.jpg | GRAPHIC | 177173
5 |  | proxynoticecard1.jpg | GRAPHIC | 232591
6 |  | proxynoticecard2.jpg | GRAPHIC | 104271
| Complete submission text file | 0000886163-14-000043.txt |  | 1862198

Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 14774425
SIC: 2834 Pharmaceutical Preparations